Short-course radiotherapy followed by CAPOX combined with tislelizumab and bevacizumab or cetuximab for treatment-naive unresectable metastatic rectal cancer (UNION mRC). - KIVIRID

Short-course radiotherapy followed by CAPOX combined with tislelizumab and bevacizumab or cetuximab for treatment-naive unresectable metastatic rectal cancer (UNION mRC).

Authors: Zhenyu Lin, Qian Xu, Haihong Wang, Tao Zhang

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e15553

Source: Full article

Abstract

e15553